Brief: CSL Currently Experiencing Temporary Global Stockout Of HEMGENIX
17/03/2026 15:50
March 17 (Reuters) - CSL Ltd CSL.AX: CSL IS CURRENTLY EXPERIENCING A TEMPORARY GLOBAL STOCKOUT OF HEMGENIX WORKING WITH REGULATORY AUTHORITIES ON STRATEGIES TO ENSURE STABLE ONGOING SUPPLY FOR HEMGENIX Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsBrief: CSL To Defend Class Action
Australia's CSL hit with shareholder class action suit over earnings guidance (updated)
Australia's CSL faces investor proceeding over disclosure obligations
Citi says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)